MERS-CoV

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic coronavirus. First identified in 2012, MERS-CoV has caused over 2460 infections and a fatality rate of about 35% in humans. Similar to severe acute respiratory syndrome coronavirus (SARS-CoV), MERS-CoV likely originated...

Descripción completa

Detalles Bibliográficos
Otros Autores:	Du, Lanying (auth), Li, Fang
Formato:	Libro electrónico
Idioma:	Inglés
Publicado:	MDPI - Multidisciplinary Digital Publishing Institute 2019
Materias:	cell–cell fusion hDPP4 n/a therapeutics animal models HCoV-229E Drivers camels rabbits SARS-CoV MERS-CoV MVA vaccine transmission RBD MERS-CoV nucleocapsid protein complement animal model pseudotyped virus combination MERS-coronavirus peptide mouse model spike protein receptor-binding domain prevention and treatment coronaviruses coronavirus spike glycoprotein therapeutic antibodies vaccine platforms mutation severe acute respiratory syndrome coronavirus pathogenesis fusion inhibitor Coronavirus murine CD8+ T cell epitope lipidomics authentic virus correlates of immunity vaccines neutralizing monoclonal antibodies Middle East respiratory syndrome coronavirus small-molecule inhibitor Middle East Respiratory Syndrome Virus DPP4 pyroptosis cross-neutralization inflammation Qatar spike proteins One Health HKU4 nanobodies mechanism of action neutralizing antibody host factors UHPLC–MS
Ver en Biblioteca Universitat Ramon Llull:	https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009433809606719